Trials / Completed
CompletedNCT02385279
Study Comparing the MiStent SES Versus the XIENCE EES Stent
Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,398 (actual)
- Sponsor
- ECRI bv · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the performance of MISTENT to that of XIENCE in an all-comers patient population with symptomatic ischemic heart disease. The patients will be followed through 3 years for major clinical events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MiStent | Percutaneous Coronary Intervention |
| DEVICE | XIENCE EES | Percutaneous Coronary Intervention |
Timeline
- Start date
- 2015-03-20
- Primary completion
- 2017-01-31
- Completion
- 2021-02-04
- First posted
- 2015-03-11
- Last updated
- 2023-05-08
- Results posted
- 2023-05-08
Locations
20 sites across 4 countries: France, Germany, Netherlands, Poland
Source: ClinicalTrials.gov record NCT02385279. Inclusion in this directory is not an endorsement.